Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T22:38:45.303Z.
Calculation as of: 2026-10-06T22:38:45.303Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bc1f4c18f19876ab16fbc38bb33c2f59d02ebf5b777874ee4386cd5e587f8fe3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
SOPHiA GENETICS S.A.
Market Cap
$619.15M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$611.57M
Free Cash Flow Yield
N/A
TTM Avg
0.02%
3Y Avg
0.02%
5Y Avg
0.02%
Market Cap
$632.16M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$634.30M
Free Cash Flow Yield
5.13%
TTM Avg
2.85%
3Y Avg
2.85%
5Y Avg
4.02%
Market Cap
$638.20M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$597.55M
Free Cash Flow Yield
31.05%
TTM Avg
16.53%
3Y Avg
24.36%
5Y Avg
19.94%
Market Cap
$596.01M
Free Cash Flow Yield
0.09%
TTM Avg
0.21%
3Y Avg
0.21%
5Y Avg
0.70%
Market Cap
$584.48M
Free Cash Flow Yield
N/A
TTM Avg
2.13%
3Y Avg
14.68%
5Y Avg
12.04%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SOPHiA GENETICS S.A. (SOPH) | $619.15M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | N/A | 0.02% | 0.02% | 0.02% |
| OmniAb, Inc. (OABI)vs › | $630.63M | N/A | 0.14% | 0.13% | 0.13% |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | N/A | N/A | N/A | N/A |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | 5.13% | 2.85% | 2.85% | 4.02% |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 31.05% | 16.53% | 24.36% | 19.94% |
| AngioDynamics, Inc. (ANGO)vs › | $596.01M | 0.09% | 0.21% | 0.21% | 0.70% |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.48M | N/A | 2.13% | 14.68% | 12.04% |
| OrthoPediatrics Corp. (KIDS)vs › | $583.31M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
